Atlas Trials

Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Clinical trial NCT00655499 · COMPLETED

Trial details

NCT number
NCT00655499
Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2008-06-01
Primary completion
2012-06-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.